Pulmonary tuberculosis in the central prison of Douala, Cameroon by Noeske, J et al.
January 2006 EAST AFRICAN MEDICAL JOURNAL 25
East African Medical Journal Vol. 83 No. 1 January 2006
PULMONARY TUBERCULOSIS IN THE CENTRAL PRISON OF DOUALA, CAMEROON
J. Noeske, MD, German Technical Cooperation, BP 4400 (gtz), Douala, Cameroon,  C. Kuaban, Prof, Université de Yaoundé I, B. P. 1274, Yaounde, Cameroon,
G. Amougou, MD, New Bell Central Prison, B.P. 4949, Douala, Cameroon, A. Piubello, MD, Catholic Health Services, Archdiocese Wouri B.P. 179, Douala,
Cameroon and R. Pouillot, MD, Centre Pasteur du Cameroun, B.P. 1274, Yaounde, Cameroon
Request for reprints to: Dr. J. Noeske, BP 4400 (gtz), Douala, Cameroon
PULMONARY TUBERCULOSIS IN THE CENTRAL PRISON OF DOUALA, CAMEROON
J. NOESKE, C. KUABAN, G. AMOUGOU, A. PIUBELLO and R. POUILLOT
ABSTRACT
Objective: To determine the prevalence of and factors associated with pulmonary
tuberculosis (PTB) in an urban prison in sub-Saharan Africa.
Design: A cross-sectional survey.
Setting: The Central Prison of Douala, Cameroon.
Results: Two thousand four hundred and seventy four (87.4%) out of 2830 inmates
underwent screening. Twenty seven (1.1%) of the inmates were under treatment for
smear-positive PTB on commencement of the survey while 60 (2.4%) were diagnosed
with smear and/or culture-positive PTB during the active case finding, resulting in a
point prevalence of PTB of 3.5%. HIV seroprevalence in inmates without clinical signs
of PTB was 111/1067 (10.4%) while it amounted to 6/24 (25%) in PTB patients. In
multiple stepwise regression analysis, a low BMl, a prison stay of ≤12 months, and a
history of previous incarceration were positively associated with PTB.
Conclusion: The study results confirm the high prevalence rates of PTB in prison
populations and underscore the need for urgent preventive measures.
INTRODUCTION
Published prevalence and incidence rates of
tuberculosis (TB) in prison populations are among the
highest notified in any population (1). While the bulk
of recent publications and articles have focused on the
TB situation in prisons in the former Soviet Union, data
on the prevalence of TB in prisons in sub-Saharan
African countries are limited. Based on active screening,
studies from Ivory Coast (2), Malawi (3,4), Tanzania
(5) and Botswana (6) have, however, found TB
prevalence rates in prisons 6-30 times higher than the
national rates.
Cameroon, a sub-Saharan African country with a
population of about 16.5 millions inhabitants, set up
its National Tuberculosis Control Programme (NTCP)
based on the recommendations of the UNION and
WHO in 1997. For 2003, the incidence rate of smear-
positive (sm+) pulmonary TB (PTB) cases was estimated
at 78 per 100,000 population (7). While the detection
rates of cases are still to catch up with the estimated
incidence rates of sm+ PTB, TB case notification within
the NTCP increased between 1997 and 2004 from 544
to 18,400, with 69% of these being new sm+ PTB
cases. Fifty six percent of all new sm+ PTB cases are
males aged between 15 and 54 years (non published
data of the NTCP, 2004). It is thought that the
increasing incidence rates are due to the unfavourable
socio-economic conditions and the rising prevalence of
human immunodeficiency virus (HIV) in the country.
Indeed, according to 2004 revised estimates of WHO/
UNAIDS (8), 5.5% (4.8-9.8%) of sexually active adults
(15-49 years old) in Cameroon are living with HIV/
AIDS. Huge differences do however exist in different
regions of the country. In Douala, the economic capital,
about 3.7% of the adult male population is infected.
At the start of this study in 2003, the prison
population in Cameroon’s 76 prisons, according to
semi-official statistics (9), stood at 21,000 persons or
127 prisoners for 100,000 population, the highest prison
population rate in Central Africa (in comparison:
Nigeria 34/100,000, Chad 48/100,000). About one third
of this prison population is incarcerated in the central
prisons of either Yaounde, the administrative capital,
or Douala.
In Cameroon, prison health care can be considered
as sub-standard and completely underfunded. The drug
budget for the year 2004 for New Bell Central Prison
(Douala) was an equivalent of 550 USD. In general,
prisoners who cannot pay or find a family member to
help pay for their health care are not taken care of.
Prison health personnel is scarce with only eight
medical doctors sharing the medical responsibility for
the country’s entire prison population including the
guards. Prisoners are not systematically screened for
TB and data on TB and/or HIV/AIDS prevalence in
Cameroonian prisons are non-existent. To prepare for
the setting up of a comprehensive TB control programme
in the Central Prison of Douala we decided to ascertain
the prevalence of pulmonary tuberculosis in inmates of
26 EAST AFRICAN MEDICAL JOURNAL January 2006
this prison through active case finding as well as to
study some predictors of the disease.
MATERIALS AND METHODS
Study setting: New Bell Central Prison, the sole
penitentiary facility for Douala, the economic capital city of
Cameroon, was built in 1930. It is Cameroon’s second largest
prison and although initially built for 700 inmates, it houses
between 2750 and 3150 prisoners. Living and sanitary
conditions in the prison, reminiscent of all Cameroonian
prisons, are extremely deplorable. Half of the cells house
more than 150 inmates with a surface area of less than 0.20m2
per inmate. The cells are extremely poorly ventilated and
practically receive no sunlight. The prison has an infirmary
comprising an outpatient clinic, an eight-bed ward, a laboratory
and a pharmacy. Cases of tuberculosis are routinely identified
in this prison through passive case finding. Only patients who
present to the clinic with cough of three weeks duration or
more are investigated for pulmonary tuberculosis if the
financial means necessary for the laboratory investigations are
available. Care to TB cases in prisons is sometimes provided
by representatives of various churches or lay persons for
humanitarian reasons. This is often rather selective (aiming
at the church members).
Methods: Between October 2003 and February 2004, we
received permission from the central and local prison authorities
in Cameroon to carry out an active case finding survey in
the New Bell Central Prison of Douala to identify cases of
pulmonary tuberculosis. Three physicians with several years
of experience in tuberculosis control screened the prisoners
in the prison’s infirmary. All inmates aged 15 years and above
were systematically invited cell after cell for this exercise.
The inmates of a cell were called upon only once for
screening. Some prisoners were out of prison confinement
during the day of survey for several reasons, some refused
to participate and therefore not all prisoners could be
screened. Screening however took place early in the mornings
to minimise the number of absentees due to community
service or attendance at court sessions. From each screened
prisoner, the following information was obtained: cell number,
age, sex, length of current stay in prison and history of
previous incarceration as well as past history of tuberculosis.
They were also asked if they had cough currently and if they
were presently taking treatment for tuberculosis. For those
currently on anti-tuberculosis treatment precision was obtained
about the onset of their illness, the type of tuberculosis and
the date on which they started anti-tuberculosis therapy. For
prisoners who had a current cough and were not on tuberculosis
treatment, the duration of their symptoms was sought for and
recorded. All prisoners screened were weighed and their
height measured. Body weight was determined to the nearest
0.1 kg using a SECA adult balance and standing height was
determined to the nearest 2 mm. Body mass index (BMI)
defined as weight in kg divided by height in m2 was
calculated for each screened prisoner.
Since prison is a potentially high risk environment for
tuberculosis transmission and since in some settings it has
been observed that some respiratory patients with cough
between 1 and 3 weeks may be sputum-smear positive for
acid fast bacilli (AFB) (3,10), we arbitrarily took a symptomatic
period of two weeks or more of cough to increase the
sensitivity of the screening procedure. Each prisoner who had
a cough of two weeks duration or more was assigned a unique
study number and investigated for tuberculosis. These prisoners
were asked to submit one early morning sputum sample on
two consecutive days. The two sputum samples were examined
by smear microscopy for acid-fast bacilli (AFB) with the
Ziehl-Neelsen stain in the prison laboratory.
Prisoners with sputum smears positive for AFB were
started on short course chemotherapy as recommended by
NTCP. Prisoners who were sputum smear negative were
given a 10-day course of a broad-spectrum antibiotic, generally
cotrimoxazole. If their cough did not improve after this course
of non-specific broad-spectrum antibiotherapy, a second
series of two early morning sputum samples was collected
as described above and examined for AFB. One of the sputum
samples from each of these patients notwithstanding whether
they were AFB positive or not was sent to the mycobacteriology
laboratory of the Centre Pasteur du Cameroun in Yaounde
for culture. Prisoners whose sputum smears were positive for
AFB on this second series of sputum samples as well as those
whose sputum yielded positive cultures for M. tuberculosis
were placed on anti-tuberculosis treatment. Those whose
sputum smears and/or cultures were negative, were referred
for further investigations in the chest service of the Hôpital
Laquintinie in Douala. A case of pulmonary tuberculosis was
defined in this study as a smear and/or culture positive
prisoner. The Figure summarises the process of screening and
diagnosing pulmonary tuberculosis during the survey.
Figure
Algorithm for detection of PTB in New Bell Central
Prison
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All prisoners who were screened for pulmonary
tuberculosis were offered voluntary counselling and testing
(VCT) for HIV in accordance with the recommendations of
the National AIDS Programme in Cameroon. A blood sample
was collected from each consenting prisoner. HIV antibodies
were detected using two rapid tests: Determine® HIV-1/2
(Abbott Laboratories, Tokyo, Japan) and Immunocomb® II
HIV 1 and 2 BiSpot (Orgenics, Courbevoie, France). When
the two tests were positive, the inmate was considered
positive for HIV. In case of discordant results, a confirmation
test was carried out by the Western blot technique (New Lav
Blot®, Sanofi Diagnostics, Pasteur). Cotrimoxazole was
offered free of charge to those with a confirmed positive test
result.
Statistical analysis: Data were collected and analysed
by the Epi-Info software programme (Version 6.04b, Centers
for Disease Control, Atlanta, G.A., USA). The Chi square
test or Fisher’s exact test was used to compare propositions
while means were compared by the Student’s t-test. A
difference was considered significant if p<0.05. Variables
found to be associated with PTB with p<0.20 value were re-
examined in a logistic regression model using R software
(Version 2.0.1; The R Development Core Team©).
RESULTS
During the study period, the mean number of
inmates was 2830 out of whom 2474 (87.4%) were
screened for PTB. The median age of the inmates
screened was 27 years (range 15-79 years) and the
majority of them (2407 or 97.3%) were men. The
median stay in the prison before the screening exercise
for these inmates was five months (range: 1 day to 29
years). Of the 2474 prisoners screened, 363 (14.7%)
had a history of previous incarceration and 98 (3.9%)
recalled having been treated for tuberculosis in the past.
Among the latter, 28 (28.6%) had a past history of
incarceration. The nutritional status of the inmates
showed wide variations and the median BMI was 20.48
kg/m2. Five hundred and forty six (22.1%) of the
screened inmates were malnourished, malnutrition being
defined as a BMI of ≤18.5 kg/m2. About 10% of the
inmates suffered from severe skin diseases, mostly
scabies.
Of the 2474 inmates screened, 27 (1.1%) were
receiving anti-TB treatment for PTB at the time of the
screening exercise. Four hundred and sixty eight (19.1%)
of the 2447 remaining inmates fulfilled the criteria for
sputum smear examination. Of these, 442 (94.4%) gave
sputum samples for sputum smear examination and 47
(10.6%) were smear positive on microscopic examination
for AFB. Three hundred and eighty four (97.2%) of
the remaining 395 inmates whose sputum smears were
negative for AFB were put on cotrimoxazole for ten
days. On completion of this treatment, 61 (5.9%) of
them still presented with persisting symptoms and a
second series of sputum smear examinations for AFB
was performed. From these, seven (11.5%) were positive
for AFB. Sixty of 61 sputum samples obtained from
these inmates for culture gave 13 positive cultures for
M. tuberculosis, six of them obtained from samples of
inmates who were smear-negative for AFB on the
second series of sputum microscopic examination. In
total, 60 inmates were found in this survey to be either
sputum smear and/or culture-positive (47 during the
first series of sputum smear examinations, seven during
a second series of sputum smear examinations after
completion of a 10 day course of non-specific
antibiotherapy and six after culture). On addition of
these cases to the 27 PTB cases already on treatment
during the screening process, the total number of PTB
patients in the New Bell Central Prison at the time of
the study was 87. This gives a minimum point prevalence
of 3,517 cases per 100,000 inmates.
The prison had 25 cells, one of them being a cell
where prisoners are temporarily kept before being
dispatched to one of the other cells. Of the 24
permanent cells, 18 (75%) had at least two cases of
contagious tuberculosis (median 3, range 2-11). In the
temporary cell, two cases were detected. Of the six cells
not harbouring cases, five were small cells with less
than 20 inmates with a ‘privileged’ status (police/army
officers, foreigners, civil servants, well to-do business
men), and the sixth the relatively isolated female
inmates’ cell.
Voluntary counselling and testing for HIV was
offered to all inmates screened. Twenty four (28%) of
the 87 PTB cases, 61 (15%) of the 418 symptomatic
but smear and/or culture-negative inmates and 1067
(54%) of the 1969 asymptomatic prisoners accepted to
be tested. Table 1 shows the proportions of those with
a positive HIV serology in the three groups. While there
was no significant difference in the HIV seroprevalence
rate between PTB cases and symptomatic cases, this rate
was significantly higher in the group of PTB when
compared to the group of asymptomatic cases (p = 0.04).
Table 1
HIV-seropositive in mates among PTB, PTB suspects and asymptomatic prisoners
Number offered Number accepted Number positive
VCT test (%) for HIV test (%)
PTB patients 87 24 (28) 6 (25.0, 95%CI: 10-47)
PTB suspects (cough ≥2 weeks) 418 61 (15) 13 (21.3, 95%CI: 12-34)
Prisoners without clinical signs 1,969 1067 (54) 111 (10.4, 95%CI: 9-12)
and symptoms of PTB
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The characteristics of inmates with and without
smear and/or culture positive pulmonary tuberculosis
are shown in Table 2. Univariate analysis revealed that
having PTB in this prison setting was positively
associated with inmates having (i) a BMI ≤18.5 kg/m2
(p<0.01), (ii) a duration of imprisonment of ≤12 months
(p=0.01), (iii) a history of previous incarceration
(p=0.03), and (iv) HIV co-infection (p = 0.04). Multiple
stepwise regression analysis, excluding HIV co-infection
due to low acceptance among the inmates, confirmed
the former three associations to be independently
associated with PTB in prisoners (Table 3).
DISCUSSION
The point prevalence of PTB among inmates in
New Bell Central Prison during the study period was
3.5%. After adjusting for age and sex, this prevalence
was 35 times higher than the one found in the male
population of Douala. A high monthly turn-over of
about 5% of the prisoners in the different prison cells
as well as the absence of inmates due to temporary
permissions, forced labour inside or outside the prison,
appearance before the court or simple refusal to be
screened (in a few cases) did not permit the screening
Table 2
Univariate analysis of baseline characteristics of inmates with PTB in the New Bell Central Prison of Douala
Variable No. PTB OR 95%CI P-value
Age group (years)*
   15-24 882 33 1
    ≥25 1588 54 0.91 0.59-1.44 0.19
BMI **
    >18.50 1932 44 1
    ≤18.50 539 43 3.90 2.48-6.14 <0.01
Duration of
incarceration (months)
    >12 629 12 1
    0-12 1845 75 2.18 1.14-4.25 0.01
Previous
incarceration
    No 2109 67 1
    Yes 365 20 1.77 1.02-3.02 0.03
Previous history of PTB
    No 2376 80 1
    Yes 98 7 2.21 0.91-5.12 0.08
HIV infection
    No 956 18 1
    Yes 111 4 2.87 1.00-7.87 0.04
*Four values are lacking; **Three values are lacking
Table 3
Factors significantly associated with PTB in inmates in the New Bell Central Prison, multivariate analysis
Variable* No. PTB OR 95% CI P-value
BMI*
    > 18.50 1932 44
    ≤18.50 539 43 3.97 2.57-6.14 <0.01
Duration of
incarceration (months)
    >12 629 12
    0-12 1845 75 2.89 1.27-4.48 0.01
Previous
incarceration
    No 2109 67
    Yes 365 20 1.96 1.13-3.25 0.01
*2471 data available for analysis
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of all inmates. The approximately 400 prisoners not
screened and/or having abandoned their screening
procedure on different moments of this survey may
have constituted a healthier part of the prison population
and therefore could introduce a bias towards an
overestimation of the prevalence rate of PTB in this
prison. On the other hand, however, only symptomatic
inmates with prolonged (≥2 weeks) productive cough
were eligible for screening and only those with
bacteriologicaly confirmed PTB were retained as TB
cases. The prevalence rate observed in this survey may
therefore be an underestimation of the actual rate
because due to logistic reasons (lack of chest X-ray
facilities) we missed asymptomatic as well as sputum
smear negative cases. This notwithstanding, the high
PTB case rate found in this prison as compared to that
observed in the general population corroborate results
obtained from similar studies or observations obtained
during cross sectional studies in Ivory Coast (2),
Malawi (3,4), and Tanzania (5).
During the survey, HIV testing was offered to all
prisoners after counselling. Acceptance to be tested was
particularly low among prisoners identified with PTB
and those with prolonged cough without PTB. The
reasons for this low acceptance are not clear as we did
not investigate them. Nevertheless, although the data
base is relatively weak to give a convincing statistically
significant association between PTB and HIV infection,
the results do suggest, as would have been expected,
this association. HIV-infection was found in 25%
(95%CI: 10-47) of PTB prisoners who accepted to be
tested in this study. This is comparable to the 25-42%
of HIV infection observed in PTB patients outside the
prison (11). Of prisoners without symptoms for PTB,
54% accepted HIV testing and of these 10.4% were
HIV infected. The demographic and other characteristics
of inmates who accepted HIV testing did not differ
significantly from those who did not accept it. The
proportion of asymptomatic inmates infected by HIV
was substantially higher than the 3.5% HIV prevalence
rate observed in a comparable general male population
in the city of Douala. In western countries, high-risk
factors for HIV transmission in penitentiary facilities
include intravenous injection of drugs, sexual abuse,
and homosexual activity (12,13). In Cameroonian
prisons, intravenous drug use is very uncommon.
However, homosexual activity and abuse, although
illegal and not considered as a societal norm, are known
to occur frequently in our prisons. As the inmates are
mostly young and sexually active men, these may
constitute the main modes of HIV transmission among
the New Bell Central Prison population.
A low BMI (≤18.5), a current prison stay of 12
months or less, a history of former incarceration and
HIV-infection showed a significant relationship with
PTB in this study on univariate analysis (Table 2). Of
these factors, a low BMI, a current prison stay of 12
months or less and a history of former incarceration
remained significant predictors of PTB in a multivariate
analysis (Table 3). Incarceration as well as HIV-
infection (even though not a significant predictor in this
study probably due to the small sample size) are well
documented risk factors for TB disease (12,14).
Malnutrition equally is recognised as a risk factor for
the reactivation of latent TB and its progression to
disease (15). This link is besides bi-directional as TB
can cause or predispose to malnutrition (16). Hence
when comparing individuals with and without active
PTB in this cross-sectional study with respect to their
nutritional status, a causal effect can not be assigned
to malnutrition, even though it came out as a significant
predictor in the multivariate analysis. Moreover it is
also claimed that scientific evidence for a causal
relationship between malnutrition and the development
of TB disease are weak and that the biological
link between the two morbid states is still not well
understood (17,18).
The development of TB observed in inmates in
the New Bell Central Prison may also be linked to a
complex of other adverse conditions like overcrowding,
or immune down-regulation by psycho-social stress in
inmates with latent TB-infection or prolonged exposure
to infective but untreated patients. All these factors
while being possible independent risk factors for the
development of TB, can also interact synergistically.
The association observed between a stay of 12 months
or less in prison and the occurrence of PTB in our study
may likewise be part of this complex of adverse
circumstances. At first glance, the observation of a
“protective” effect of a longer prison stay vis à vis the
development of PTB may seem counter-intuitive; after
all, duration of exposure and infection and/or
development of disease are supposed to be positively
related. Yet the passage from life outside the prison
to a situation of incarceration with its attendant
traumatizing disruption of survival conditions may be
compared to the situation of individuals confronted with
complex emergency situations where the highest excess
morbidity and mortality are well known to occur during
the acute phase of the emergency (18). Sudden
overcrowding, absence of individual shelter, absent
psycho-social reference systems, impoverishment,
slimming as a result of food shortages, exposure to
infectious individuals with no or poor access to health
care can be imagined as so many stress factors that
can increase the vulnerability to transmission of TB
infection or reactivation of latent TB infection and
progression to disease. In the long run and after
adopting survival strategies inmates may be thought to
have established a new balance with stress diminishing
and vulnerability decreasing. Results of studies in
similar settings to ours looking at the association of
the duration of prison stay and the development of TB
disease are not concordant. While in some settings TB
disease occurs more frequently in the first or second
year of imprisonment (2-5), studies from other settings
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report the risk for TB to be greater with a longer
duration of incarceration (6).
The results of this study were communicated to
the Cameroonian health and prison authorities. It was
agreed that there was an urgent need to set up a
comprehensive TB and HIV control programme in the
country’s prisons so as to counteract the spread of both
infections in this setting. Emphasis will be put on the
creation of TB diagnostic and treatment centres in
prisons with systematic screening of all new prisoners
for PTB on entry, and the entire prison population
including prison staff once a year, separation of all
infectious patients from the prisons’ general population,
supervision of prison TB activities by the NTCP and
engagement of an NGO to administer an HIV prevention
programme including voluntary counselling and testing
of inmates and guards, under supervision of the National
Aids Control Programme. Other additional measures
that will need to be taken should focus on the
improvement of living conditions in the prison.
In conclusion, the prevalence of PTB in the New
Bell Central Prison of Douala is quite high and suggests
that there may be active transmission of tuberculosis
in this setting. A low BMI (≤18.5 kg/m2), a current
prison stay of 12 months or less and a history of former
incarceration were found to be significantly associated
with PTB in this prison. As a result of this survey,
the Cameroonian health and prison authorities have
resolved to put up progressively a comprehensive
package for TB and HIV control in the countrys’
prisons.
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